Risk of finding an endometrial cancer when atypical hyperplasia was incidentally diagnosed on hysteroscopic resection products

Eur J Obstet Gynecol Reprod Biol. 2002 Jun 10;103(1):58-9. doi: 10.1016/s0301-2115(02)00005-2.

Abstract

Objective: To evaluate the risk of discovering an endometrial cancer when atypical hyperplasia was diagnosed by histologic examination of hysteroscopic resection products.

Study design: A retrospective monocentric study from January 1994 to January 2001. Seventeen patients with atypical hyperplasia were included. Initial endometrial status was provided by operative hysteroscopy resection products. For all patients, there was no hysteroscopical aspect evocative of adenocarcinoma. Histopathological analysis of the hysterectomy pieces precised the final diagnosis.

Results: Among the 17 hysterectomy pieces, one adenocarcinoma was diagnosed. Risk for discovering adenocarcinoma when atypical hyperplasia was diagnosed by operative hysteroscopy resection products was 5.9% (1/17).

Conclusion: Risk of omitting adenocarcinoma when atypical hyperplasia is discovered by hysteroscopy resection pieces is low.

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / pathology
  • Adult
  • Aged
  • Endometrial Hyperplasia / diagnosis*
  • Endometrial Hyperplasia / pathology
  • Endometrial Hyperplasia / surgery
  • Endometrial Neoplasms / diagnosis*
  • Endometrial Neoplasms / pathology
  • Female
  • Humans
  • Hysterectomy*
  • Hysteroscopy*
  • Middle Aged